Aging isn’t one problem.

Most longevity products give you one piece of the puzzle. A wearable gives you a stream of signals. A lab gives you biomarkers. A biological-age test gives you a score. A clinician can diagnose and prescribe. A treatment can change something. All of those can be useful. The problem is that they mostly live in separate worlds.

Amity is meant to be the layer that connects them. It keeps your wearables, blood tests, medical history, medications, goals, prior interventions, and responses in one longitudinal picture, then helps answer the question those tools usually leave unanswered: what, if anything, should happen next?

That distinction matters because aging is messy. Metabolism changes. Cardiovascular risk changes. Immune function changes. Body composition changes. Different tissues and pathways change at different rates. A marker can move once because of noise, move repeatedly because something real is happening, or matter only when you combine it with other signals.

So the useful question isn’t “what anti-aging thing should everyone take?” It’s “given everything we know about this person right now, is there actually a reason to do something?”

Sometimes the answer is no. If a change is weak, transient, or unlikely to alter the plan, Amity should say so. You shouldn’t get another blood draw just because a blood draw is available. You shouldn’t add another supplement or drug just because somebody published an exciting paper.

Sometimes the answer is to test. Not “test everything,” but test the thing that can actually resolve a decision. Maybe a wearable trend is suspicious enough that a blood marker is worth checking. Maybe one abnormal lab should be repeated before anybody acts on it. Maybe a treatment changed one signal and now it’s time to see whether the effect held.

And sometimes the answer is to intervene. When the evidence is persistent enough, the potential benefit is meaningful enough, and there’s a reasonable action to take, Amity can surface that next step for a clinician and patient to consider.

This is also why connecting the data matters so much. A wearable on its own can tell you that resting heart rate changed. A lab on its own can tell you that ApoB changed. Your history might show a medication change at the same time. Your prior response might show that the last intervention helped one marker and hurt another. Amity’s job is to keep those things together instead of making you reason across five apps, a PDF, and a spreadsheet.

That’s a very different product from a dashboard. A dashboard can show you fifty numbers beautifully and still leave you with no idea what to do. Amity should make the complexity disappear. It can ingest a lot of information in the background, but what reaches you should be simple: this matters, this doesn’t, here’s the next thing worth doing.

It’s also different from a static longevity protocol. A fixed stack assumes the same set of interventions keeps making sense. But people change. Their risk changes. Their biomarkers change. Their goals change. New evidence appears. And, most importantly, people respond differently. Something that was worth doing six months ago may not be worth doing now.

So Amity doesn’t stop when it recommends something. If you intervene, the next question is what should change, how long that should take, and when it’s worth measuring again. The result feeds back into the plan. If it worked, that becomes evidence. If it didn’t, that becomes evidence too.

That closed loop is the core of the product. Measurements change decisions. Decisions lead to actions. Actions create new measurements. Over time, your own history becomes part of the evidence for what should happen next.

And Amity doesn’t need to replace everything else for that to be powerful. We want it to work with the ecosystem that already exists. Wearables can keep sensing. Labs can keep measuring. Clinicians can diagnose and prescribe. New anti-aging treatments can enter as the science improves. Amity can sit across all of it and keep the whole system pointed at one goal: helping you stay healthier for longer.

Today, doing serious longevity work often means becoming your own care coordinator and research analyst. You read papers, compare tests, track experiments, remember when you started something, wonder when to retest, and try to work out whether a change was real. That’s ridiculous as a consumer experience.

We think the better version is almost boring from the user’s perspective. Amity keeps watch. Most of the time, you live your life. When something is actually worth your attention, it tells you why and what to do next.

The goal isn’t a better longevity dashboard. It’s a system that can actually help manage aging: connect the signals, decide what matters, choose the next action, measure the result, and keep getting smarter about you.